Stable IgG-antibody levels in patients with mild SARS-CoV-2 infection

  1. Thomas Åkerlund
  2. Katherina Zakikhany
  3. Charlotta Löfström
  4. Evelina Lindmark
  5. Henrik Källberg
  6. Ulla Elofsson
  7. Karin Cederbrant
  8. Erik Nygren
  9. Anders Kallin
  10. Nina Lagerqvist
  11. Peter Nilsson
  12. Sophia Hober
  13. Anna Ridderstad Wollberg
  14. Åsa Szekely Björndal
1 evaluations Published on
Read the full article Related papers
This article on Sciety

Abstract

More knowledge regarding persistence of antibody response to SARS-CoV-2 infections in the general population with mild symptoms is needed. We measured and compared levels of SARS-CoV-2 spike- and nucleocapsid-specific IgG-antibodies in serum samples from 145 laboratory-confirmed COVID-19 cases and 324 non-cases. The IgG-antibody levels against the spike protein in cases were stable over the time-period studied (14 to 256 days), while antibody levels against the nucleocapsid protein decreased over time.

Related articles

Related articles are currently not available for this article.